[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351559-105":59,"doc-detail-351559-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","bladder-cancer-incidence-trends-in-the-united-states-from-2000-to-2020","Bladder Cancer Incidence Trends in the United States From 2000 to 2020","","Bladder cancer is a leading urogenital malignancy worldwide. The study analyzes incidence trends in the United States between 2000 and 2020, stratified by age, sex, and race/ethnicity, and further evaluates histologic subtypes using SEER data. Age-standardized, delay-adjusted incidence rates are computed, applying a delay model across key registry and diagnostic variables. Joinpoint trend analyses exclude 2020 incidence data while presenting it separately.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/bladder-cancer-incidence-trends-in-the-united-states-from-2000-to-2020/351559/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/bladder-cancer-incidence-trends-in-the-united-states-from-2000-to-2020/351559.png","ImageObject",300,407,{"name":92,"@type":93},"Bintang","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main objective of the study?","Question",{"text":112,"@type":113},"To report bladder cancer incidence trends in the United States from 2000 to 2020, stratified by age, sex, race/ethnicity, and tumor types using SEER data.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were incidence rates calculated?",{"text":117,"@type":113},"The analysis used SEER 22 data to compute age-standardized and delay-adjusted incidence rates, with a delay model adjusting for variables such as cancer site, registry, age group, race/ethnicity, and year of diagnosis.",{"name":119,"@type":110,"acceptedAnswer":120},"What major trends were found over 2000–2019?",{"text":121,"@type":113},"The study found a significant decrease in the age-standardized incidence rate across races/ethnicities in both sexes within all age groups, with reported average annual percent change values around −0.95% for men and −1.02% for women.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},351559,1790155196,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962085564381,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Cancer Reports  \nORIGINAL ARTICLE  OPEN ACCESS   \nBladder Cancer Incidence Trends in the United States From 2000 to 2020  \nSeyed Ehsan Mousavi1,2  | Ryan Michael Antar3  | Armin Aslani1  | Pourya Shokri4  | Zahra Yekta5  | Amin Bateni6  | Nasser Shakhssalim7  | Seyed Aria Nejadghaderi8,9   \n1Neurosciences Research Center, Aging Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran | 2Faculty of Medicine, Social Determinants of Health Research Center, Department of Community Medicine, Tabriz University of Medical Sciences, Tabriz, Iran | 3School of Medicine & Health Sciences, The George Washington University, Washington, District of Columbia, USA | 4School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran | 5Calaveras County Department of Health, Calaveras County, California, USA | 6Department of Community Medicine, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran | 7Urology and Nephrology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran | 8HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran | 9Knowledge Hub for Migrant and Refugee Health, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran  \nCorrespondence: Seyed Ehsan Mousavi ([drehsanmousavii@gmail.com](drehsanmousavii@gmail.com)) | Seyed Aria Nejadghaderi ([a.nejadghaderi@kmu.ac.ir](a.nejadghaderi@kmu.ac.ir); [ariang20@gmail.com](ariang20@gmail.com))  \nReceived: 29 January 2025 | Revised: 13 February 2026 | Accepted: 8 April 2026  \nKeywords: bladder cancer | bladder neoplasm | epidemiology | incidence | SEER | surveillance, epidemiology, and end results | United States  \nABSTRACT  \nBackground: Bladder cancer is one of the most common urogenital cancers globally. Here, we aimed to report the incidence trend of bladder cancer in the United States (US) over 2000–2020, by age, sex, race/ethnicity, and types using Surveillance, Epidemiology, and End Results (SEER) .  \nMethods: We used SEER 22 data to calculate the age-standardized and delay-adjustment incidence rate of bladder cancer. Only individuals diagnosed with cancer and whose age at diagnosis was known were included in the study. A delay model was applied, adjusting for variables such as cancer site, registry, age group, race/ethnicity, and year of diagnosis. Using the Tiwari technique, the same database was also used to determine the age-standardized incidence rate (ASIR) of subtypes. The incidence data for 2020 were excluded from Joinpoint trends while displayed separately in illustrations.  \nResults: Over 2000–2019, most bladder cancer cases were urothelial carcinoma (92.99%), among non-Hispanic Whites (84.48%) and those aged 70 to 84 years (45.72%) . There was a significant decrease in the ASIR of bladder cancer across all races/ethnicities in both sexes within all age groups (Average annual percent change (AAPC): −0.95%; [−1.06, −0.83] for men and −1.02%[−1.21,−0.84] for women) over 2000–2019. The incidence rates decreased by 6.23% during the COVID-19 pandemic. Also, the delayadjusted incidence rate of bladder cancer increased with advancing age.  \nConclusions: Despite a decrease in ASIR of bladder cancer over 2000–2019, there are still a high number of incident cases, particularly among NHWs and the elderly. Future studies should investigate the underlying causes of bladder cancer incidence trends among demographic groups.  \n\n| Abbreviations: AAPC, average annual percent change; APC, annual percent change; ASIR, age-standardized incidence rate; MIBC, muscle-invasive bladder cancer; NHB, non-hispanic black; NHW, non-hispanic white; SCC, squamous cell carcinoma; SEER, surveillance, epidemiology, and end results; US, United States. |\n| --- |\n| This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribu","cbCaikFh2Kn5ogpZ","https://ap.wps.com/l/cbCaikFh2Kn5ogpZ","pdf",1341140,17,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"What was the main objective of the study?\",\"answer\":\"To report bladder cancer incidence trends in the United States from 2000 to 2020, stratified by age, sex, race/ethnicity, and tumor types using SEER data.\"},{\"question\":\"How were incidence rates calculated?\",\"answer\":\"The analysis used SEER 22 data to compute age-standardized and delay-adjusted incidence rates, with a delay model adjusting for variables such as cancer site, registry, age group, race/ethnicity, and year of diagnosis.\"},{\"question\":\"What major trends were found over 2000–2019?\",\"answer\":\"The study found a significant decrease in the age-standardized incidence rate across races/ethnicities in both sexes within all age groups, with reported average annual percent change values around −0.95% for men and −1.02% for women.\"}]","Bladder Cancer Incidence Trends in the United States From 2000 to 2020 | PDF",1790094711,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/de10a9955bf831d8e09af9677df9c056.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/72fd72054293acd9ebf483a6ab08049d.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/96817fc707f00894304b2616820a07ed.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/002f9336b8bd36a9a93faf47bcf11164.webp",980,1287]